Patent Number: 7,786,070

Title: Subcutaneous administration of coagulation factor VII

Abstract: The invention relates to the use of a Factor VIIa for the manufacture of a medicament for treatment of a condition affectable by Factor VIIa, said medicament being for subcutaneous, intramuscular or intradermal administration, and to the use of a Factor VIIa for the manufacture of a medicament for treatment of a condition affectable by Factor VIIa, wherein said medicament, when administered subcutaneously, intradermally or intramuscularly, shows a prolonged biological half-life.

Inventors: Johannessen; Marie (Birkerod, DK), Nordfang; Ole Juul (Hillerod, DK), Jansen; Jens Aas (Charlottenlund, DK)

Assignee: Novo Nordisk HealthCare A/G

International Classification: C12N 9/50 (20060101)

Expiration Date: 8/31/12018